Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Vaidyane Ayurved Laboratories's Days Inventory or its related term are showing as below:
NSE:MADHAVBAUG'
s Days Inventory Range Over the Past 10 Years
Min: 25.77 Med: 54.5 Max: 76.9
Current: 69.39
During the past 8 years, Vaidyane Ayurved Laboratories's highest Days Inventory was 76.90. The lowest was 25.77. And the median was 54.50.
NSE:MADHAVBAUG's Days Inventory is ranked better than 89.37% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.58
vs NSE:MADHAVBAUG: 69.39
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vaidyane Ayurved Laboratories's Inventory Turnover for the
six
months ended in Mar. 2026 was 3.02.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vaidyane Ayurved Laboratories's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.06.
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vaidyane Ayurved Laboratories's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vaidyane Ayurved Laboratories's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vaidyane Ayurved Laboratories Days Inventory Related Terms
Vaidyane Ayurved Laboratories Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories Days Inventory Chart
NSE:MADHAVBAUG vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaidyane Ayurved Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vaidyane Ayurved Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a Days Inventory of 60.39 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vaidyane Ayurved Laboratories and its competitors. This is 11% above median its historical median of 54.50. Over the past decade, Vaidyane Ayurved Laboratories' Days Inventory has ranged from 25.77 to 76.90. According to the industry distribution chart, Vaidyane Ayurved Laboratories ranks #98 out of 922 companies in the Drug Manufacturers industry, placing it in the top 10.6%.
Is Vaidyane Ayurved Laboratories' Days Inventory too high?
Vaidyane Ayurved Laboratories' current Days Inventory of 60.39 is 11% above median its 10-year median of 54.50. Over the past 10 years, this metric has ranged from a low of 25.77 to a high of 76.90. The Drug Manufacturers industry median Days Inventory is 164.58. Vaidyane Ayurved Laboratories' value of 60.39 is 63.3% below this industry median. Based on the distribution chart, Vaidyane Ayurved Laboratories ranks #98 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vaidyane Ayurved Laboratories ranks #98 out of 922 companies for Days Inventory. This places Vaidyane Ayurved Laboratories in the top 11% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.58. Vaidyane Ayurved Laboratories' value of 60.39 is 63.3% below this benchmark. Historically, Vaidyane Ayurved Laboratories' own Days Inventory has ranged from 25.77 to 76.90 over the past decade. While the company's 10-year median is 54.50 vs. the industry median of 164.58, Vaidyane Ayurved Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.58, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaidyane Ayurved Laboratories's current Days Inventory of 60.39 is 63.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vaidyane Ayurved Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaidyane Ayurved Laboratories's current Days Inventory is 60.39, which is 11% above median its own 10-year median of 54.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹228.14, compared to a current price of ₹204.85 — trading 10.2% below its estimated fair value. The current Days Inventory is 60.39, which is 11% above median its 10-year median of 54.50 and 63.3% below the Drug Manufacturers industry median of 164.58. Vaidyane Ayurved Laboratories' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current Days Inventory is 60.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued.
The current stock price of ₹204.85 is trading 10.2% below its estimated GF Value™ of ₹228.14.
GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.
Key valuation signals for NSE:MADHAVBAUG:
Days Inventory: 60.39 (11% above median its 10-year median of 54.50)
GF Value™: ₹228.14 vs. price of ₹204.85 (10.2% below fair value)
Industry Position: 63.3% below the Drug Manufacturers median (#98 of 922)
No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vaidyane Ayurved Laboratories Business Description
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
78GF Score
Get the complete analysis for NSE:MADHAVBAUG
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MADHAVBAUG has been successfully added to your 
